16-BRE-50-PU (PUMA-NER-1301) A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients with Her2+ Metastatic Breast Cancer Who Have Received Two or More Prior Her2-Directed Regimens in the Metastatic Setting

  • Mathew, Aju (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date1/23/175/16/18